aluates Reports

$ 0.0

Automative

Global Peptide CRO/CDMO Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-16C19287

BUY CHAPTERS

Global Peptide CRO/CDMO Market Research Report 2025

Code: QYRE-Auto-16C19287

Report

May 2025

Pages:109

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Peptide CRO/CDMO Market Size

The global market for Peptide CRO/CDMO was valued at US$ 3521 million in the year 2024 and is projected to reach a revised size of US$ 7361 million by 2031, growing at a CAGR of 11.4% during the forecast period.

Peptide CRO/CDMO Market

Peptide CRO/CDMO (Contract Research Organization/Contract Development and Manufacturing Organization) refers to specialized service providers focused on the research, process development, large-scale production, and quality control of peptide-based drugs and active molecules. These organizations offer end-to-end solutions to pharmaceutical companies, biotech firms, and research institutions—from candidate screening and synthesis process development to pilot production and commercial manufacturing. Equipped with core technologies in high-purity peptide synthesis, modification, purification, and analytical testing, peptide CRO/CDMOs play an increasingly vital role in drug discovery and the broader biopharmaceutical supply chain, especially with the growing use of peptide drugs in oncology, metabolic diseases, and vaccine development.

North American market for Peptide CRO/CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Peptide CRO/CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Peptide CRO/CDMO in Pharmaceutical and Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Peptide CRO/CDMO include Polypeptide, Bachem, CordenPharma, JPT Peptide, Pepscan, LONZA, Neuland Labs, PeptiDream, WuXi AppTec, Asymchem, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Peptide CRO/CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide CRO/CDMO.

The Peptide CRO/CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide CRO/CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peptide CRO/CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Peptide CRO/CDMO Market Report

Report Metric	Details
Report Name	Peptide CRO/CDMO Market
Accounted market size in year	US$ 3521 million
Forecasted market size in 2031	US$ 7361 million
CAGR	11.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Peptide CRO Peptide CDMO
Segment by Application	Pharmaceutical and Biotechnology Companies Research Institutions
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Polypeptide, Bachem, CordenPharma, JPT Peptide, Pepscan, LONZA, Neuland Labs, PeptiDream, WuXi AppTec, Asymchem, GL Biochem, Shenzhen JYMed Technology, Chengdu Shengnuo Biotechnology, Jiangsu Sinopep-Allsino Biopharmaceutical, Medtide, AmbioPharm, Anhui Anke Biotechnology, Pharmaron, Zhejiang Jiuzhou Pharmaceutical, Genscript, Zonsen PepLib Biotech, Zhejiang Peptites Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide CRO/CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Peptide CRO/CDMO Market growing?

Ans: The Peptide CRO/CDMO Market witnessing a CAGR of 11.4% during the forecast period 2025-2031.

What is the Peptide CRO/CDMO Market size in 2031?

Ans: The Peptide CRO/CDMO Market size in 2031 will be US$ 7361 million.

Who are the main players in the Peptide CRO/CDMO Market report?

Ans: The main players in the Peptide CRO/CDMO Market are Polypeptide, Bachem, CordenPharma, JPT Peptide, Pepscan, LONZA, Neuland Labs, PeptiDream, WuXi AppTec, Asymchem, GL Biochem, Shenzhen JYMed Technology, Chengdu Shengnuo Biotechnology, Jiangsu Sinopep-Allsino Biopharmaceutical, Medtide, AmbioPharm, Anhui Anke Biotechnology, Pharmaron, Zhejiang Jiuzhou Pharmaceutical, Genscript, Zonsen PepLib Biotech, Zhejiang Peptites Biotech

What are the Application segmentation covered in the Peptide CRO/CDMO Market report?

Ans: The Applications covered in the Peptide CRO/CDMO Market report are Pharmaceutical and Biotechnology Companies, Research Institutions

What are the Type segmentation covered in the Peptide CRO/CDMO Market report?

Ans: The Types covered in the Peptide CRO/CDMO Market report are Peptide CRO, Peptide CDMO

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peptide CRO/CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Peptide CRO

1.2.3 Peptide CDMO

1.3 Market by Application

1.3.1 Global Peptide CRO/CDMO Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical and Biotechnology Companies

1.3.3 Research Institutions

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Peptide CRO/CDMO Market Perspective (2020-2031)

2.2 Global Peptide CRO/CDMO Growth Trends by Region

2.2.1 Global Peptide CRO/CDMO Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Peptide CRO/CDMO Historic Market Size by Region (2020-2025)

2.2.3 Peptide CRO/CDMO Forecasted Market Size by Region (2026-2031)

2.3 Peptide CRO/CDMO Market Dynamics

2.3.1 Peptide CRO/CDMO Industry Trends

2.3.2 Peptide CRO/CDMO Market Drivers

2.3.3 Peptide CRO/CDMO Market Challenges

2.3.4 Peptide CRO/CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Peptide CRO/CDMO Players by Revenue

3.1.1 Global Top Peptide CRO/CDMO Players by Revenue (2020-2025)

3.1.2 Global Peptide CRO/CDMO Revenue Market Share by Players (2020-2025)

3.2 Global Top Peptide CRO/CDMO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Peptide CRO/CDMO Revenue

3.4 Global Peptide CRO/CDMO Market Concentration Ratio

3.4.1 Global Peptide CRO/CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peptide CRO/CDMO Revenue in 2024

3.5 Global Key Players of Peptide CRO/CDMO Head office and Area Served

3.6 Global Key Players of Peptide CRO/CDMO, Product and Application

3.7 Global Key Players of Peptide CRO/CDMO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide CRO/CDMO Breakdown Data by Type

4.1 Global Peptide CRO/CDMO Historic Market Size by Type (2020-2025)

4.2 Global Peptide CRO/CDMO Forecasted Market Size by Type (2026-2031)

5 Peptide CRO/CDMO Breakdown Data by Application

5.1 Global Peptide CRO/CDMO Historic Market Size by Application (2020-2025)

5.2 Global Peptide CRO/CDMO Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Peptide CRO/CDMO Market Size (2020-2031)

6.2 North America Peptide CRO/CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Peptide CRO/CDMO Market Size by Country (2020-2025)

6.4 North America Peptide CRO/CDMO Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Peptide CRO/CDMO Market Size (2020-2031)

7.2 Europe Peptide CRO/CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Peptide CRO/CDMO Market Size by Country (2020-2025)

7.4 Europe Peptide CRO/CDMO Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Peptide CRO/CDMO Market Size (2020-2031)

8.2 Asia-Pacific Peptide CRO/CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Peptide CRO/CDMO Market Size by Region (2020-2025)

8.4 Asia-Pacific Peptide CRO/CDMO Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Peptide CRO/CDMO Market Size (2020-2031)

9.2 Latin America Peptide CRO/CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Peptide CRO/CDMO Market Size by Country (2020-2025)

9.4 Latin America Peptide CRO/CDMO Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Peptide CRO/CDMO Market Size (2020-2031)

10.2 Middle East & Africa Peptide CRO/CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Peptide CRO/CDMO Market Size by Country (2020-2025)

10.4 Middle East & Africa Peptide CRO/CDMO Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Polypeptide

11.1.1 Polypeptide Company Details

11.1.2 Polypeptide Business Overview

11.1.3 Polypeptide Peptide CRO/CDMO Introduction

11.1.4 Polypeptide Revenue in Peptide CRO/CDMO Business (2020-2025)

11.1.5 Polypeptide Recent Development

11.2 Bachem

11.2.1 Bachem Company Details

11.2.2 Bachem Business Overview

11.2.3 Bachem Peptide CRO/CDMO Introduction

11.2.4 Bachem Revenue in Peptide CRO/CDMO Business (2020-2025)

11.2.5 Bachem Recent Development

11.3 CordenPharma

11.3.1 CordenPharma Company Details

11.3.2 CordenPharma Business Overview

11.3.3 CordenPharma Peptide CRO/CDMO Introduction

11.3.4 CordenPharma Revenue in Peptide CRO/CDMO Business (2020-2025)

11.3.5 CordenPharma Recent Development

11.4 JPT Peptide

11.4.1 JPT Peptide Company Details

11.4.2 JPT Peptide Business Overview

11.4.3 JPT Peptide Peptide CRO/CDMO Introduction

11.4.4 JPT Peptide Revenue in Peptide CRO/CDMO Business (2020-2025)

11.4.5 JPT Peptide Recent Development

11.5 Pepscan

11.5.1 Pepscan Company Details

11.5.2 Pepscan Business Overview

11.5.3 Pepscan Peptide CRO/CDMO Introduction

11.5.4 Pepscan Revenue in Peptide CRO/CDMO Business (2020-2025)

11.5.5 Pepscan Recent Development

11.6 LONZA

11.6.1 LONZA Company Details

11.6.2 LONZA Business Overview

11.6.3 LONZA Peptide CRO/CDMO Introduction

11.6.4 LONZA Revenue in Peptide CRO/CDMO Business (2020-2025)

11.6.5 LONZA Recent Development

11.7 Neuland Labs

11.7.1 Neuland Labs Company Details

11.7.2 Neuland Labs Business Overview

11.7.3 Neuland Labs Peptide CRO/CDMO Introduction

11.7.4 Neuland Labs Revenue in Peptide CRO/CDMO Business (2020-2025)

11.7.5 Neuland Labs Recent Development

11.8 PeptiDream

11.8.1 PeptiDream Company Details

11.8.2 PeptiDream Business Overview

11.8.3 PeptiDream Peptide CRO/CDMO Introduction

11.8.4 PeptiDream Revenue in Peptide CRO/CDMO Business (2020-2025)

11.8.5 PeptiDream Recent Development

11.9 WuXi AppTec

11.9.1 WuXi AppTec Company Details

11.9.2 WuXi AppTec Business Overview

11.9.3 WuXi AppTec Peptide CRO/CDMO Introduction

11.9.4 WuXi AppTec Revenue in Peptide CRO/CDMO Business (2020-2025)

11.9.5 WuXi AppTec Recent Development

11.10 Asymchem

11.10.1 Asymchem Company Details

11.10.2 Asymchem Business Overview

11.10.3 Asymchem Peptide CRO/CDMO Introduction

11.10.4 Asymchem Revenue in Peptide CRO/CDMO Business (2020-2025)

11.10.5 Asymchem Recent Development

11.11 GL Biochem

11.11.1 GL Biochem Company Details

11.11.2 GL Biochem Business Overview

11.11.3 GL Biochem Peptide CRO/CDMO Introduction

11.11.4 GL Biochem Revenue in Peptide CRO/CDMO Business (2020-2025)

11.11.5 GL Biochem Recent Development

11.12 Shenzhen JYMed Technology

11.12.1 Shenzhen JYMed Technology Company Details

11.12.2 Shenzhen JYMed Technology Business Overview

11.12.3 Shenzhen JYMed Technology Peptide CRO/CDMO Introduction

11.12.4 Shenzhen JYMed Technology Revenue in Peptide CRO/CDMO Business (2020-2025)

11.12.5 Shenzhen JYMed Technology Recent Development

11.13 Chengdu Shengnuo Biotechnology

11.13.1 Chengdu Shengnuo Biotechnology Company Details

11.13.2 Chengdu Shengnuo Biotechnology Business Overview

11.13.3 Chengdu Shengnuo Biotechnology Peptide CRO/CDMO Introduction

11.13.4 Chengdu Shengnuo Biotechnology Revenue in Peptide CRO/CDMO Business (2020-2025)

11.13.5 Chengdu Shengnuo Biotechnology Recent Development

11.14 Jiangsu Sinopep-Allsino Biopharmaceutical

11.14.1 Jiangsu Sinopep-Allsino Biopharmaceutical Company Details

11.14.2 Jiangsu Sinopep-Allsino Biopharmaceutical Business Overview

11.14.3 Jiangsu Sinopep-Allsino Biopharmaceutical Peptide CRO/CDMO Introduction

11.14.4 Jiangsu Sinopep-Allsino Biopharmaceutical Revenue in Peptide CRO/CDMO Business (2020-2025)

11.14.5 Jiangsu Sinopep-Allsino Biopharmaceutical Recent Development

11.15 Medtide

11.15.1 Medtide Company Details

11.15.2 Medtide Business Overview

11.15.3 Medtide Peptide CRO/CDMO Introduction

11.15.4 Medtide Revenue in Peptide CRO/CDMO Business (2020-2025)

11.15.5 Medtide Recent Development

11.16 AmbioPharm

11.16.1 AmbioPharm Company Details

11.16.2 AmbioPharm Business Overview

11.16.3 AmbioPharm Peptide CRO/CDMO Introduction

11.16.4 AmbioPharm Revenue in Peptide CRO/CDMO Business (2020-2025)

11.16.5 AmbioPharm Recent Development

11.17 Anhui Anke Biotechnology

11.17.1 Anhui Anke Biotechnology Company Details

11.17.2 Anhui Anke Biotechnology Business Overview

11.17.3 Anhui Anke Biotechnology Peptide CRO/CDMO Introduction

11.17.4 Anhui Anke Biotechnology Revenue in Peptide CRO/CDMO Business (2020-2025)

11.17.5 Anhui Anke Biotechnology Recent Development

11.18 Pharmaron

11.18.1 Pharmaron Company Details

11.18.2 Pharmaron Business Overview

11.18.3 Pharmaron Peptide CRO/CDMO Introduction

11.18.4 Pharmaron Revenue in Peptide CRO/CDMO Business (2020-2025)

11.18.5 Pharmaron Recent Development

11.19 Zhejiang Jiuzhou Pharmaceutical

11.19.1 Zhejiang Jiuzhou Pharmaceutical Company Details

11.19.2 Zhejiang Jiuzhou Pharmaceutical Business Overview

11.19.3 Zhejiang Jiuzhou Pharmaceutical Peptide CRO/CDMO Introduction

11.19.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Peptide CRO/CDMO Business (2020-2025)

11.19.5 Zhejiang Jiuzhou Pharmaceutical Recent Development

11.20 Genscript

11.20.1 Genscript Company Details

11.20.2 Genscript Business Overview

11.20.3 Genscript Peptide CRO/CDMO Introduction

11.20.4 Genscript Revenue in Peptide CRO/CDMO Business (2020-2025)

11.20.5 Genscript Recent Development

11.21 Zonsen PepLib Biotech

11.21.1 Zonsen PepLib Biotech Company Details

11.21.2 Zonsen PepLib Biotech Business Overview

11.21.3 Zonsen PepLib Biotech Peptide CRO/CDMO Introduction

11.21.4 Zonsen PepLib Biotech Revenue in Peptide CRO/CDMO Business (2020-2025)

11.21.5 Zonsen PepLib Biotech Recent Development

11.22 Zhejiang Peptites Biotech

11.22.1 Zhejiang Peptites Biotech Company Details

11.22.2 Zhejiang Peptites Biotech Business Overview

11.22.3 Zhejiang Peptites Biotech Peptide CRO/CDMO Introduction

11.22.4 Zhejiang Peptites Biotech Revenue in Peptide CRO/CDMO Business (2020-2025)

11.22.5 Zhejiang Peptites Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Peptide CRO/CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Peptide CRO

Table 3. Key Players of Peptide CDMO

Table 4. Global Peptide CRO/CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Peptide CRO/CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Peptide CRO/CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Peptide CRO/CDMO Market Share by Region (2020-2025)

Table 8. Global Peptide CRO/CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Peptide CRO/CDMO Market Share by Region (2026-2031)

Table 10. Peptide CRO/CDMO Market Trends

Table 11. Peptide CRO/CDMO Market Drivers

Table 12. Peptide CRO/CDMO Market Challenges

Table 13. Peptide CRO/CDMO Market Restraints

Table 14. Global Peptide CRO/CDMO Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Peptide CRO/CDMO Market Share by Players (2020-2025)

Table 16. Global Top Peptide CRO/CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide CRO/CDMO as of 2024)

Table 17. Ranking of Global Top Peptide CRO/CDMO Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Peptide CRO/CDMO Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Peptide CRO/CDMO, Headquarters and Area Served

Table 20. Global Key Players of Peptide CRO/CDMO, Product and Application

Table 21. Global Key Players of Peptide CRO/CDMO, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Peptide CRO/CDMO Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Peptide CRO/CDMO Revenue Market Share by Type (2020-2025)

Table 25. Global Peptide CRO/CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Peptide CRO/CDMO Revenue Market Share by Type (2026-2031)

Table 27. Global Peptide CRO/CDMO Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Peptide CRO/CDMO Revenue Market Share by Application (2020-2025)

Table 29. Global Peptide CRO/CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Peptide CRO/CDMO Revenue Market Share by Application (2026-2031)

Table 31. North America Peptide CRO/CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Peptide CRO/CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Peptide CRO/CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Peptide CRO/CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Peptide CRO/CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Peptide CRO/CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Peptide CRO/CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Peptide CRO/CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Peptide CRO/CDMO Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Peptide CRO/CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Peptide CRO/CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Peptide CRO/CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Peptide CRO/CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Peptide CRO/CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Peptide CRO/CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 46. Polypeptide Company Details

Table 47. Polypeptide Business Overview

Table 48. Polypeptide Peptide CRO/CDMO Product

Table 49. Polypeptide Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 50. Polypeptide Recent Development

Table 51. Bachem Company Details

Table 52. Bachem Business Overview

Table 53. Bachem Peptide CRO/CDMO Product

Table 54. Bachem Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 55. Bachem Recent Development

Table 56. CordenPharma Company Details

Table 57. CordenPharma Business Overview

Table 58. CordenPharma Peptide CRO/CDMO Product

Table 59. CordenPharma Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 60. CordenPharma Recent Development

Table 61. JPT Peptide Company Details

Table 62. JPT Peptide Business Overview

Table 63. JPT Peptide Peptide CRO/CDMO Product

Table 64. JPT Peptide Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 65. JPT Peptide Recent Development

Table 66. Pepscan Company Details

Table 67. Pepscan Business Overview

Table 68. Pepscan Peptide CRO/CDMO Product

Table 69. Pepscan Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 70. Pepscan Recent Development

Table 71. LONZA Company Details

Table 72. LONZA Business Overview

Table 73. LONZA Peptide CRO/CDMO Product

Table 74. LONZA Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 75. LONZA Recent Development

Table 76. Neuland Labs Company Details

Table 77. Neuland Labs Business Overview

Table 78. Neuland Labs Peptide CRO/CDMO Product

Table 79. Neuland Labs Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 80. Neuland Labs Recent Development

Table 81. PeptiDream Company Details

Table 82. PeptiDream Business Overview

Table 83. PeptiDream Peptide CRO/CDMO Product

Table 84. PeptiDream Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 85. PeptiDream Recent Development

Table 86. WuXi AppTec Company Details

Table 87. WuXi AppTec Business Overview

Table 88. WuXi AppTec Peptide CRO/CDMO Product

Table 89. WuXi AppTec Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 90. WuXi AppTec Recent Development

Table 91. Asymchem Company Details

Table 92. Asymchem Business Overview

Table 93. Asymchem Peptide CRO/CDMO Product

Table 94. Asymchem Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 95. Asymchem Recent Development

Table 96. GL Biochem Company Details

Table 97. GL Biochem Business Overview

Table 98. GL Biochem Peptide CRO/CDMO Product

Table 99. GL Biochem Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 100. GL Biochem Recent Development

Table 101. Shenzhen JYMed Technology Company Details

Table 102. Shenzhen JYMed Technology Business Overview

Table 103. Shenzhen JYMed Technology Peptide CRO/CDMO Product

Table 104. Shenzhen JYMed Technology Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 105. Shenzhen JYMed Technology Recent Development

Table 106. Chengdu Shengnuo Biotechnology Company Details

Table 107. Chengdu Shengnuo Biotechnology Business Overview

Table 108. Chengdu Shengnuo Biotechnology Peptide CRO/CDMO Product

Table 109. Chengdu Shengnuo Biotechnology Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 110. Chengdu Shengnuo Biotechnology Recent Development

Table 111. Jiangsu Sinopep-Allsino Biopharmaceutical Company Details

Table 112. Jiangsu Sinopep-Allsino Biopharmaceutical Business Overview

Table 113. Jiangsu Sinopep-Allsino Biopharmaceutical Peptide CRO/CDMO Product

Table 114. Jiangsu Sinopep-Allsino Biopharmaceutical Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 115. Jiangsu Sinopep-Allsino Biopharmaceutical Recent Development

Table 116. Medtide Company Details

Table 117. Medtide Business Overview

Table 118. Medtide Peptide CRO/CDMO Product

Table 119. Medtide Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 120. Medtide Recent Development

Table 121. AmbioPharm Company Details

Table 122. AmbioPharm Business Overview

Table 123. AmbioPharm Peptide CRO/CDMO Product

Table 124. AmbioPharm Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 125. AmbioPharm Recent Development

Table 126. Anhui Anke Biotechnology Company Details

Table 127. Anhui Anke Biotechnology Business Overview

Table 128. Anhui Anke Biotechnology Peptide CRO/CDMO Product

Table 129. Anhui Anke Biotechnology Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 130. Anhui Anke Biotechnology Recent Development

Table 131. Pharmaron Company Details

Table 132. Pharmaron Business Overview

Table 133. Pharmaron Peptide CRO/CDMO Product

Table 134. Pharmaron Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 135. Pharmaron Recent Development

Table 136. Zhejiang Jiuzhou Pharmaceutical Company Details

Table 137. Zhejiang Jiuzhou Pharmaceutical Business Overview

Table 138. Zhejiang Jiuzhou Pharmaceutical Peptide CRO/CDMO Product

Table 139. Zhejiang Jiuzhou Pharmaceutical Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 140. Zhejiang Jiuzhou Pharmaceutical Recent Development

Table 141. Genscript Company Details

Table 142. Genscript Business Overview

Table 143. Genscript Peptide CRO/CDMO Product

Table 144. Genscript Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 145. Genscript Recent Development

Table 146. Zonsen PepLib Biotech Company Details

Table 147. Zonsen PepLib Biotech Business Overview

Table 148. Zonsen PepLib Biotech Peptide CRO/CDMO Product

Table 149. Zonsen PepLib Biotech Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 150. Zonsen PepLib Biotech Recent Development

Table 151. Zhejiang Peptites Biotech Company Details

Table 152. Zhejiang Peptites Biotech Business Overview

Table 153. Zhejiang Peptites Biotech Peptide CRO/CDMO Product

Table 154. Zhejiang Peptites Biotech Revenue in Peptide CRO/CDMO Business (2020-2025) & (US$ Million)

Table 155. Zhejiang Peptites Biotech Recent Development

Table 156. Research Programs/Design for This Report

Table 157. Key Data Information from Secondary Sources

Table 158. Key Data Information from Primary Sources

Table 159. Authors List of This Report

List of Figures

Figure 1. Peptide CRO/CDMO Picture

Figure 2. Global Peptide CRO/CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Peptide CRO/CDMO Market Share by Type: 2024 VS 2031

Figure 4. Peptide CRO Features

Figure 5. Peptide CDMO Features

Figure 6. Global Peptide CRO/CDMO Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Peptide CRO/CDMO Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceutical and Biotechnology Companies Case Studies

Figure 9. Research Institutions Case Studies

Figure 10. Peptide CRO/CDMO Report Years Considered

Figure 11. Global Peptide CRO/CDMO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Peptide CRO/CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Peptide CRO/CDMO Market Share by Region: 2024 VS 2031

Figure 14. Global Peptide CRO/CDMO Market Share by Players in 2024

Figure 15. Global Peptide CRO/CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 16. The Top 10 and 5 Players Market Share by Peptide CRO/CDMO Revenue in 2024

Figure 17. North America Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Peptide CRO/CDMO Market Share by Country (2020-2031)

Figure 19. United States Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Peptide CRO/CDMO Market Share by Country (2020-2031)

Figure 23. Germany Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Peptide CRO/CDMO Market Share by Region (2020-2031)

Figure 31. China Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Peptide CRO/CDMO Market Share by Country (2020-2031)

Figure 39. Mexico Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Peptide CRO/CDMO Market Share by Country (2020-2031)

Figure 43. Turkey Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Peptide CRO/CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Polypeptide Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 47. Bachem Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 48. CordenPharma Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 49. JPT Peptide Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 50. Pepscan Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 51. LONZA Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 52. Neuland Labs Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 53. PeptiDream Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 54. WuXi AppTec Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 55. Asymchem Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 56. GL Biochem Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 57. Shenzhen JYMed Technology Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 58. Chengdu Shengnuo Biotechnology Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 59. Jiangsu Sinopep-Allsino Biopharmaceutical Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 60. Medtide Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 61. AmbioPharm Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 62. Anhui Anke Biotechnology Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 63. Pharmaron Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 64. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 65. Genscript Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 66. Zonsen PepLib Biotech Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 67. Zhejiang Peptites Biotech Revenue Growth Rate in Peptide CRO/CDMO Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Peptide CRO/CDMO Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-16C19287

Global Peptide CRO/CDMO Market Research Report 2025

FEATURED COMPANIES

Peptide CRO/CDMO Market Size

Peptide CRO/CDMO Market

Scope of Peptide CRO/CDMO Market Report

Chapter Outline

FAQ for this report

How fast is Peptide CRO/CDMO Market growing?

What is the Peptide CRO/CDMO Market size in 2031?

Who are the main players in the Peptide CRO/CDMO Market report?

What are the Application segmentation covered in the Peptide CRO/CDMO Market report?

What are the Type segmentation covered in the Peptide CRO/CDMO Market report?

FEATURED COMPANIES

RELATED REPORTS